Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 28,262Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Bayer (Switzerland) Ag

02 7Bayer Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi oral solution

Dosage Form : Oral Solution

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 28/05/2020

Application Number : 67282

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 2000mg/100ml

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 1000mg/50ml

Packaging :

Approval Date : 18-08-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank